Abstract
Transnational drug companies are moving their clinical trials business to India, giving a new urgency to clinical trials registry reform there. Patralekha Chatterjee reports.
MeSH terms
-
Clinical Trials as Topic / ethics*
-
Drug Evaluation / ethics*
-
Drug Industry / ethics*
-
Ethics Committees, Research
-
Humans
-
India
-
Public Health Administration / ethics*
-
Registries*
-
Safety